SCHEMBL19903846

SCHEMBL19903846

CNc1c(O)ccc(C(O)CNCc2ccc(C=O)cc2)c1/C=C\C=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 6/20 0.36
▸ ADRB3 P13945 4/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ ADRB1 P08588 4/20 0.33
▸ ADRA1D P25100 3/20 0.33
▸ DRD2 P14416 2/20 0.33
▸ XDH P47989 2/20 0.32
▸ SLC16A3 O15427 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ADRA2A P08913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23223709 0.79 ADRB2 (0.39) ADRB2ADRB1ADRA2AADRA2BADRA2C
SCHEMBL21573538 0.77 ADRB2 (0.43) ADRB2ADRB3RAB9AADRB1DRD2
SCHEMBL24404490 0.77 ADRB2 (0.38) ADRB2
SCHEMBL20373657 0.76 ADRB2 (0.40) ADRB2ADRB1DRD2DRD3
SCHEMBL24404566 0.75 ADRB2 (0.40) ADRB2
SCHEMBL21573495 0.74 ADRB2 (0.42) ADRB2ADRB1DRD2
SCHEMBL23223736 0.74 ADRB2 (0.39) ADRB2ADRB3RAB9AADRB1LMNA
SCHEMBL23223711 0.67 HTR2A (0.38) ADRB2
SCHEMBL18602165 0.67 ADRA2A (0.38) ADRB2ADRB3CYP3A4NFKB1MAPK1
SCHEMBL22839900 0.67 BACE1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928890-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2018-02-28 — — EP disclosed
Send feedback